SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading update

30 Apr 2021 07:00

RNS Number : 1450X
Rotork PLC
30 April 2021
 

30 April 2021

Rotork Plc

Trading update

Activity continued to improve in the first quarter. COVID-19 uncertainty remains

Rotork plc ("Rotork"), the global flow control and instrumentation group, today issues the following trading update covering the first quarter period from 1 January to 4 April 2021 ahead of its Annual General Meeting to be held later today.

COVID-19 update

All our production facilities are currently open and operating at close to normal output levels. Several were however impacted by COVID-19 closures early in the period. Whilst every effort is being made to keep our facilities open, we will not hesitate to close them if required or if we believe there is any risk to our colleagues or their families or friends.

Trading update

Performance in the period was in-line with our expectations. Order intake (on an organic constant currency basis, "OCC") was mid-single digits below the 2020 comparator, which was only modestly affected by COVID-19. Revenue was up mid-single digits year-on-year on an OCC basis, in part reflecting the weighting of first half 2020 sales to the second quarter.

Like many global businesses we are seeing elevated logistics costs and disruption to some supply routes as well as commodity cost escalation. In order to mitigate the higher logistics costs we introduced temporary surcharges on the most affected routes earlier this year. Commodity cost inflation is anticipated to be largely offset by our January price increase.

Our Growth Acceleration Programme ("GAP") is on track. We continue to see the benefits of our market re-alignment which was completed a year ago. Our investments in Rotork Site Services and in innovation and new product development are also yielding benefits. Our GAP priorities in 2021 include supply chain optimisation and our IT solutions roll-out.

Rotork continues to be highly cash generative with a strong balance sheet and net cash of £190.8m at 4 April 2021 (£178.1m at 31 December 2020). The current cash position reflects the decision to pay the £54.9m dividend (6.3p per share) in respect of 2020 in one payment (on 21 May 2021).

We continue to strengthen our business and are well placed to benefit from recovering demand. Whilst the outlook for our end markets is improved, COVID-19 related uncertainty remains. We remain committed to delivering sustainable mid to high single digit revenue growth and mid 20s adjusted operating profit margins over time.

Rotork will publish 2021 half-year results on Tuesday 3 August 2021.

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

About Rotork

Rotork is a market-leading global provider of mission-critical flow control and instrumentation solutions for oil & gas, water and wastewater, power, chemical, process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,400 people, has manufacturing facilities in 20 locations and serves 173 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLASAIAFIL
Date   Source Headline
2nd Sep 20192:49 pmRNSTotal Voting Rights
22nd Aug 201911:50 amRNSDirector/PDMR Shareholding
14th Aug 20192:20 pmRNSDirector/PDMR Shareholding
6th Aug 201912:43 pmRNSDividend Declaration
6th Aug 20197:00 amRNS2019 Half Year Results
1st Aug 20193:35 pmRNSTotal Voting Rights
23rd Jul 20193:31 pmRNSDirector/PDMR Shareholding
15th Jul 20194:46 pmRNSDirector/PDMR Shareholding
1st Jul 20194:07 pmRNSTotal Voting Rights
1st Jul 20194:05 pmRNSBlock listing Interim Review
24th Jun 20193:07 pmRNSDirector/PDMR Shareholding
20th Jun 20192:22 pmRNSHolding(s) in Company
13th Jun 201912:56 pmRNSDirector/PDMR Shareholding
3rd Jun 201911:56 amRNSTotal Voting Rights
21st May 20193:44 pmRNSDirector/PDMR Shareholding
21st May 20193:34 pmRNSDirector/PDMR Shareholding
14th May 20193:11 pmRNSDirector/PDMR Shareholding
1st May 20193:25 pmRNSTotal Voting Rights
26th Apr 20193:36 pmRNSResult of AGM
26th Apr 20197:00 amRNSTrading Update
25th Apr 20193:57 pmRNSDirector/PDMR Shareholding
25th Apr 20193:56 pmRNSDirector/PDMR Shareholding
11th Apr 20194:50 pmRNSDirector/PDMR Shareholding
1st Apr 20192:33 pmRNSTotal Voting Rights
27th Mar 20191:05 pmRNSDirector/PDMR Shareholding
27th Mar 201912:54 pmRNSDirector/PDMR Shareholding
27th Mar 201912:54 pmRNSDirector/PDMR Shareholding
25th Mar 20194:26 pmRNSDirector/PDMR Shareholding
25th Mar 20193:11 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
4th Mar 20197:00 amRNS2018 Full Year Results
1st Mar 201911:32 amRNSTotal Voting Rights
1st Mar 20197:00 amRNSCompany Secretary Change
27th Feb 20192:23 pmRNSDirector/PDMR Shareholding
5th Feb 20199:09 amRNSTotal Voting Rights
21st Jan 201912:08 pmRNSPublication Dates 2019
21st Jan 201912:07 pmRNSDirector/PDMR Shareholding
2nd Jan 20199:56 amRNSBlock listing Interim Review
2nd Jan 20199:52 amRNSTotal Voting Rights
21st Dec 201811:19 amRNSDirector/PDMR Shareholding
18th Dec 20185:17 pmRNSDirector/PDMR Shareholding - Amended
17th Dec 20183:28 pmRNSDirector/PDMR Shareholding
17th Dec 20183:24 pmRNSDirector/PDMR Shareholding
6th Dec 20184:04 pmRNSHolding(s) in Company
4th Dec 20189:57 amRNSDirector/PDMR Shareholding
3rd Dec 201810:32 amRNSTotal Voting Rights
28th Nov 20187:00 amRNSDirectorate Change
23rd Nov 20183:30 pmRNSDirector/PDMR Shareholding
23rd Nov 20183:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSTrading Update
5th Nov 20188:06 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.